Commerzbank Aktiengesellschaft’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-31,964	Closed	-$479	–	1070
2016 Q2	$479	Sell	31,964 -5,037	-14%	-$64.7K	﹤0.01%	689
2016 Q1	$450K	Buy	37,001 +5,884	+19%	+$82.5K	﹤0.01%	729
2015 Q4	$495K	Buy	31,117 +5,162	+20%	+$81.3K	﹤0.01%	877
2015 Q3	$398K	Buy	25,955 +14,010	+117%	+$303K	﹤0.01%	868
2015 Q2	$290K	Buy	+11,945	New	+$286K	﹤0.01%	1074

Commerzbank Aktiengesellschaft's SGNT Position: Q3 2016 in Review

Commerzbank Aktiengesellschaft sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 31,964 shares — an estimated $479 sold.

Commerzbank Aktiengesellschaft first reported a position in SGNT in Q2 2015 and held it in 5 quarters. The position peaked at $495K in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Commerzbank Aktiengesellschaft reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 31,964 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $479.
Commerzbank Aktiengesellschaft first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 5 quarters.
Commerzbank Aktiengesellschaft's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $495K in Q4 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2016, filed 14 Nov 2016.